Valuation: Kwality Pharmaceuticals Limited

Market Cap 35.25B 371M 330M 306M 278M 525M 534M 3.68B 1.44B 18.39B 1.39B 1.36B 58.63B P/E 2025
22.6x
P/E 2026 20.1x
Enterprise Value 36.52B 385M 342M 317M 288M 544M 553M 3.81B 1.49B 19.06B 1.44B 1.41B 60.75B EV / Sales 2025
2.7x
EV / Sales 2026 2.95x
Free-Float
22.51%
Yield 2025 *
-
Yield 2026 -
09-20 Kwality Pharmaceuticals Limited(BSE:539997) added to S&P Global BMI Index CI
09-02 Kwality Pharmaceuticals Limited Appoints Swanith Kapoor, as the Non-Executive Independent Director, Effective 02 June, 2026 CI
08-10 Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
06-02 Kwality Pharmaceuticals Limited Announces Resignation of Kartik Kapur as Independent Director, Effective June 02, 2026 CI
05-19 Kwality Pharmaceuticals' Consolidated Profit Rises in Fiscal Q4; Shares Jump 9% MT
05-19 Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027 CI
05-19 Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
03-11 Chatha Foods Limited Announces Change in Designation of Mrs. Rachna Singh Chaudhary as Chief Human Resource Officer, Effective March 11, 2026 CI
03-10 Kwality Pharmaceuticals completes phase 1 BE studies for three molecules RE
02-12 Kwality Pharmaceuticals' Consolidated Profit Jumps in Fiscal Q3; Shares Surge 16% MT
02-12 Kwality Pharmaceuticals Ltd Dec-quarter consol net profit 160.1 million rupees RE
02-12 Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02-02 Kwality Pharmaceuticals Limited Announces Completion of Term of Pankaj Takkar and Ravi Shanker as Independent Directors and from Committees Membership and Chairmanship, Effective January 31, 2026 CI
1 day+2.41%
1 week-3.77%
Current month-6.59%
1 month-1.40%
3 months+25.41%
6 months+119.51%
Current year+206.47%
1 week 3,227
Extreme 3227
3,607.45
1 month 3,227
Extreme 3227
3,866.55
Current year 1,020
Extreme 1020
3,866.55
1 year 828.8
Extreme 828.8
3,866.55
3 years 320
Extreme 320
3,866.55
5 years 248
Extreme 248
3,866.55
10 years 21.3
Extreme 21.3
3,866.55
Manager TitleAgeSince
Chief Executive Officer 72 1983-05-03
Director of Finance/CFO 32 2015-10-21
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 72 1983-05-03
Director/Board Member 58 1995-07-31
Director/Board Member 64 2010-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%-3.77%+295.29%+871.33% 363M
+0.40%+6.75%+53.64%+104.15% 1,116B
+0.79%-2.29%+32.97%+62.17% 610B
+0.66%+3.16%+25.72%+93.72% 501B
+0.86%+0.90%+75.07%+41.07% 358B
-0.13%+5.98%+32.91%+50.39% 366B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 261B
-0.24%+4.43%+46.46%+51.02% 235B
-0.98%+3.27%+32.46%+97.11% 195B
Average +0.03%+4.14%+61.32%+142.74% 393.01B
Weighted average by Cap. +0.06%+4.93%+39.31%+71.59%

Financials

2025 2026
Net sales 3.7B 39.01M 34.67M 32.14M 29.24M 55.18M 56.06M 386M 151M 1.93B 146M 143M 6.16B 5.03B 53.01M 47.12M 43.67M 39.73M 74.98M 76.18M 525M 206M 2.63B 199M 195M 8.37B
Net income 398M 4.2M 3.73M 3.46M 3.15M 5.94M 6.03M 41.58M 16.3M 208M 15.76M 15.42M 663M 673M 7.1M 6.31M 5.85M 5.32M 10.04M 10.2M 70.27M 27.55M 351M 26.63M 26.06M 1.12B
Net Debt 977M 10.29M 9.15M 8.48M 7.72M 14.56M 14.79M 102M 39.97M 510M 38.63M 37.81M 1.63B 1.27B 13.39M 11.91M 11.03M 10.04M 18.95M 19.25M 133M 52.01M 663M 50.27M 49.2M 2.11B
Projected Income Statement - Annual - Kwality Pharmaceuticals Limited
Logo Kwality Pharmaceuticals Limited
Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.
Employees
1,137
Date Price Change Volume
26-10-16 ₹3,396.75 +2.41% 4,420
26-10-15 ₹3,316.70 -2.22% 3,995
26-10-14 ₹3,392.10 -3.92% 2,992
26-10-13 ₹3,530.45 -0.89% 2,178
26-10-12 ₹3,562.30 -0.01% 1,162

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Kwality Pharmaceuticals Limited